Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways

Hongchao Zhen,1 Guangxin Li,2 Pengfei Zhao,1 Ying Zhang,1 Jing Wang,1 Junxian Yu,3 Bangwei Cao1 1Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, People’s Republic of China; 2Radiation Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical...

Full description

Bibliographic Details
Main Authors: Zhen H, Li G, Zhao P, Zhang Y, Wang J, Yu J, Cao B
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:OncoTargets and Therapy
Subjects:
raltitrexed
apatinib
antitumor
escc
akt
erk
Online Access:https://www.dovepress.com/raltitrexed-enhances-the-antitumor-effect-of-apatinib-in-human-esophag-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/raltitrexed-enhances-the-antitumor-effect-of-apatinib-in-human-esophag-peer-reviewed-article-OTT

Similar Items